KRAS and non-small cell lung carcinoma: In this multicentre study of patients with non-squamous NSCLC, we found no differences in PFS or OS between patients with KRAS mutated and KRAS wild type NSCLC, between patients with KRAS wild type, G12C and KRAS non-G12 mutations, or among KRAS mutation subtypes.